A randomized phase II study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma: A North Central Cancer...

Por Kottschade, Lisa A., Suman, Vera J., Perez, Domingo G., McWilliams, Robert R., Kaur, Judith S., Amatruda, Thomas T., Geoffroy, Francois J., Gross, Howard M., Cohen, Peter A., Jaslowski, Anthony J., Kosel, Matthew L., Markovic, Svetomir N.
Publicado em 2012

Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177

Por Brown, Paul D., Krishnan, Sunil, Sarkaria, Jann N., Wu, Wenting, Jaeckle, Kurt A., Uhm, Joon H., Geoffroy, Francois J., Arusell, Robert, Kitange, Gaspar, Jenkins, Robert B., Kugler, John W., Morton, Roscoe F., Rowland, Kendrith M., Mischel, Paul, Yong, William H., Scheithauer, Bernd W., Schiff, David, Giannini, Caterina, Buckner, Jan C.
Publicado em 2008